6101 Stoneridge Drive, Pleasanton, California, 94588, USA
June 2011: Results are in for a post FDA approval study on survival rates for patients using continuous flow LVAD as a bridge to heart transplantation. Outcomes were excellent with 91% of HeartMate II patients achieving positive outcomes of transplant, cardiac recovery or ongoing LVAD support at 6 months. Kaplan-Meier survival for HeartMate II patients at one year was 85% and q ...
Read More...
6101 Stoneridge Drive, Pleasanton, California, 94588, USA
(from website) The HeartMate XVE (also referred to as HeartMate I) is one of the most widely used left ventricular assist devices in the world. With its low thromboembolic risk, the HeartMate XVE can be used for either Bridge-to-Transplantation or Destination Therapy (chronic support for those ineligible for cardiac transplantation.)
About - Terms of use - Privacy Policy
Upgrade Your Body (TM) is managed by Consolidated Computing Pty Ltd.